Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Bibliographic Details
Main Author:	Das, Reshita
Other Authors:	Omer, Humair Bin MD
Format:	Thesis
Language:	English
Published:	Brac University 2024
Subjects:	Molecular docking NSCLC 5GPG Structure-based drug design Lung cancer Pharmaceutical chemistry. Biomolecules > Structure. Drugs > Design. Lungs > Cancer.
Online Access:	http://hdl.handle.net/10361/23926

Similar Items

Molecules associated with the development of lung cancer
by: Rahman, Adree, et al.
Published: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
by: Hoque, Ismoth Ara
Published: (2024)

A review on principles of molecular docking and its application in drug discovery
by: Sharif Ezzaz, Ahamed
Published: (2024)

A review on recent advances in drugs for lung cancer treatment
by: Noor, Fouzia
Published: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Flora, Sanzida Alam
Published: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
by: Jeba, Joynob
Published: (2017)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
by: Zangmo, Thinley
Published: (2024)

A review on targeted therapies for lung cancer
by: Ashraf, Anushey
Published: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
by: Rahman, Tasnim
Published: (2024)

Potential of liposomes for the treatment of lung cancer- a review
by: Mim, Shanzida
Published: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
by: Razna, Amrin Islam
Published: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
by: Araf, Faiaz Fahim
Published: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
by: Paul, Pulock
Published: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
by: Tania, Umme
Published: (2023)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
by: Pial, Sazia Afrin
Published: (2018)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Karim, Samia Binte
Published: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
by: Shabnam, Musharrat
Published: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
by: Bristy, Israt Zerin
Published: (2021)

Immunotherapy in the Management of Lung Cancer
by: Tasnim, Humayra
Published: (2022)

Lung cancer detection and classification using machine learning
by: Arefin, Mahbubul, et al.
Published: (2023)

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
by: Rashed, Sadman Sakib Bin
Published: (2019)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
by: Jahan, Esrat
Published: (2020)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
by: Mukti, Roushney Fatima, et al.
Published: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
by: Nandy, Aditi
Published: (2022)

The role of cryo-electron microscopy in anticancer drug discovery and development
by: Alam, Jemima
Published: (2021)

Breast cancer therapy through Liposomal drug delivery system
by: Ome, Nusrat Jahan
Published: (2024)

A comprehensive review on drug repurposing in cancer treatment
by: Sarkar, Onusree
Published: (2024)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
by: Tabassum, Azwada
Published: (2021)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
by: Raihan, Dilraj
Published: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
by: Hoque, Syeda Mehren
Published: (2024)

Oncogenes: new targets in cancer treatment
by: Chowdhury, Waseka Shams
Published: (2020)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
by: Chakraborty, Anuradha
Published: (2024)

Role of statins as antagonists of SPARC in gastric cancer
by: Shahmat, Rad
Published: (2019)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
by: Hasan, Samir, et al.
Published: (2024)

A computational approach to find alternative drugs for managing depression
by: Mubashira, Musharrat Shaheed
Published: (2022)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
by: Rahman, Ahadina
Published: (2018)

Risk of cancer associated with antihypertensive drugs
by: Iqbal, Adnan
Published: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
by: Jahan, Nusrat
Published: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
by: Nashrah, Zannatul
Published: (2023)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
by: Nahar, Kamrun
Published: (2023)